MetLife (MET) Stock Forecast & Price Target

$81.02 -1.73 (-2.08%)

Closing price 02/21/2025 03:59 PM Eastern

Extended Trading

$80.96 -0.05 (-0.06%)

As of 02/21/2025 07:58 PM Eastern

MetLife - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy

Based on 12 Analyst Ratings

Sell
0

Hold
1

Buy
11

Based on 12 Wall Street analysts who have issued ratings for MetLife in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 12 analysts, 1 has given a hold rating, and 11 have given a buy rating for MET.

Consensus Price Target

$92.58
14.28% Upside

According to the 12 analysts' twelve-month price targets for MetLife, the average price target is $92.58. The highest price target for MET is $99.00, while the lowest price target for MET is $80.00. The average price target represents a forecasted upside of 14.28% from the current price of $81.02.

Get the Latest News and Ratings for MET and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for MetLife and its competitors.

MET Analyst Ratings Over Time

Type	Current Forecast 2/24/24 to 2/23/25	1 Month Ago 1/25/24 to 1/24/25	3 Months Ago 11/26/23 to 11/25/24	1 Year Ago 2/24/23 to 2/24/24
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	11 Buy rating(s)	12 Buy rating(s)	13 Buy rating(s)	12 Buy rating(s)
Hold	1 Hold rating(s)	1 Hold rating(s)	0 Hold rating(s)	1 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$92.58	$90.46	$88.46	$77.23
Forecasted Upside	14.28% Upside	5.23% Upside	1.26% Upside	11.40% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Buy	Moderate Buy

MET Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

MET Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

MetLife Stock vs. The Competition

Type	MetLife	Finance Companies	S&P 500
Consensus Rating Score	2.92	2.51	2.53
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy
Predicted Upside	14.28% Upside	26.63% Upside	14.35% Upside
News Sentiment Rating	Positive News See Recent MET News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
2/19/2025	Wells Fargo & Company 3 of 5 stars	Elyse Greenspan Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Overweight ➝ Overweight	$92.00 ➝ $97.00	+17.84%
2/12/2025	Keefe, Bruyette & Woods 4 of 5 stars	Ryan Krueger Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Outperform ➝ Outperform	$100.00 ➝ $98.00	+17.73%
2/7/2025	Barclays 3 of 5 stars	A. Scott Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Overweight ➝ Overweight	$96.00 ➝ $95.00	+13.10%
1/23/2025	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	Jack Matten Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Market Perform	$97.00	+13.09%
1/7/2025	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$86.00 ➝ $88.00	+6.59%
11/27/2024	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Kligerman Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Buy ➝ Buy	$97.00 ➝ $99.00	+11.50%
10/2/2024	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$85.00 ➝ $92.00	+12.46%
9/27/2024	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$89.00 ➝ $95.00	+14.71%
8/19/2024	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Overweight ➝ Overweight	$86.00 ➝ $85.00	+15.98%
8/1/2024	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy ➝ Buy	$99.00 ➝ $96.00	+24.92%
Get the Latest News and Ratings for MET and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for MetLife and its competitors with MarketBeat's FREE daily newsletter.
7/23/2024	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$83.00 ➝ $89.00	+18.26%
5/22/2024	Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$77.00 ➝ $80.00	+9.50%
2/5/2024	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy ➝ Buy	$87.00 ➝ $82.00	+24.05%
1/8/2024	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Neutral ➝ Buy	$70.00 ➝ $80.00	+16.08%
10/4/2023	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Hold	$71.00	+18.33%
8/4/2023	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$70.00 ➝ $74.00	+14.14%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 04:22 AM ET.

Should I Buy MetLife Stock? MET Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Tuesday, February 18, 2025. Please send any questions or comments about these MetLife pros and cons to contact@marketbeat.com.

MetLife
Bull Case

Here are some ways that investors could benefit from investing in MetLife, Inc.:

MetLife, Inc. has a strong consensus rating of "Moderate Buy" from analysts, indicating positive sentiment towards the stock's future performance.
The current stock price is $81.78, which is below the average target price of $92.17 set by analysts, suggesting potential for price appreciation.
Recent quarterly earnings reported an EPS of $2.08, with analysts expecting an annual EPS of 9.63, indicating solid profitability and growth potential.
The company has a dividend yield of 2.67%, providing investors with a steady income stream, which is attractive in a low-interest-rate environment.
MetLife, Inc. operates through multiple segments, including Retirement and Income Solutions and Group Benefits, diversifying its revenue sources and reducing risk.

MetLife
Bear Case

Investors should be bearish about investing in MetLife, Inc. for these reasons:

MetLife, Inc. recently missed earnings expectations by $0.05, which may raise concerns about its ability to meet future financial targets.
The stock has experienced volatility, with a 52-week range between $67.30 and $89.05, indicating potential risks associated with price fluctuations.
Analysts have issued mixed ratings, with some downgrading the stock from "buy" to "hold," reflecting uncertainty in its short-term performance.
The company's current ratio of 0.16 suggests potential liquidity issues, as it may struggle to cover short-term liabilities with its current assets.
MetLife, Inc. has a relatively high debt-to-equity ratio of 0.54, which could indicate increased financial risk if market conditions worsen.

MET Forecast - Frequently Asked Questions

: According to the research reports of 12 Wall Street equities research analysts, the average twelve-month stock price forecast for MetLife is $92.58, with a high forecast of $99.00 and a low forecast of $80.00.
: 12 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for MetLife in the last year. There is currently 1 hold rating and 11 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" MET shares.
: According to analysts, MetLife's stock has a predicted upside of 14.28% based on their 12-month stock forecasts.
: MetLife has been rated by research analysts at Barclays, BMO Capital Markets, JPMorgan Chase & Co., Keefe, Bruyette & Woods, TD Cowen, and Wells Fargo & Company in the past 90 days.
: Analysts like MetLife more than other "finance" companies. The consensus rating score for MetLife is 2.92 while the average consensus rating score for "finance" companies is 2.51. Learn more on how MET compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top-Rated Stocks

More Ratings Tools

This page (NYSE:MET) was last updated on 2/23/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

MetLife (MET) Stock Forecast & Price Target